196 related articles for article (PubMed ID: 26835989)
1. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.
Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T
Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989
[TBL] [Abstract][Full Text] [Related]
2. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonists alleviate blood-brain barrier disruption and cerebral edema in a mouse model of traumatic brain injury: A comparison between bosentan and ambrisentan.
Michinaga S; Inoue A; Yamamoto H; Ryu R; Inoue A; Mizuguchi H; Koyama Y
Neuropharmacology; 2020 Sep; 175():108182. PubMed ID: 32561219
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
[TBL] [Abstract][Full Text] [Related]
5. Endothelin ET
Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
[TBL] [Abstract][Full Text] [Related]
6. Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
Angus JA; Soeding PF; Hughes RJA; Wright CE
Eur J Pharmacol; 2017 Jun; 804():111-116. PubMed ID: 28300593
[TBL] [Abstract][Full Text] [Related]
7. TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6.
Knobloch J; Yanik SD; Körber S; Stoelben E; Jungck D; Koch A
Biochem Pharmacol; 2016 Sep; 116():188-99. PubMed ID: 27422754
[TBL] [Abstract][Full Text] [Related]
8. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
Pyuen AA; Meuten T; Rose BJ; Thamm DH
PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
[TBL] [Abstract][Full Text] [Related]
10. Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
Rodriguez AM; Graef AJ; LeVine DN; Cohen IR; Modiano JF; Kim JH
J Vet Intern Med; 2015; 29(4):1088-97. PubMed ID: 26118793
[TBL] [Abstract][Full Text] [Related]
11. Role of the endothelin axis in the proliferation of human thyroid cancer cells.
Donckier JE; Mertens-Strijthagen J; Flamion B
Clin Endocrinol (Oxf); 2007 Oct; 67(4):552-6. PubMed ID: 17561979
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 and ETA/ETB receptor protein and mRNA: expression in normal and vascularized human corneas.
Kuhlmann A; Amann K; Schlötzer-Schrehardt U; Kruse FE; Cursiefen C
Cornea; 2005 Oct; 24(7):837-44. PubMed ID: 16160501
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
15. Transfer and Vascular Effect of Endothelin Receptor Antagonists in the Human Placenta.
Hitzerd E; Neuman RI; Broekhuizen M; Simons SHP; Schoenmakers S; Reiss IKM; Koch BCP; van den Meiracker AH; Versmissen J; Visser W; Danser AHJ
Hypertension; 2020 Mar; 75(3):877-884. PubMed ID: 31884859
[TBL] [Abstract][Full Text] [Related]
16. Desmethyl bosentan displays a similar in vitro interaction profile as bosentan.
Weiss J; Baumann S; Theile D; Haefeli WE
Pulm Pharmacol Ther; 2015 Feb; 30():80-6. PubMed ID: 25535031
[TBL] [Abstract][Full Text] [Related]
17. Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12.
Maguire JJ; Davenport AP
Br J Pharmacol; 2014 Dec; 171(24):5555-72. PubMed ID: 25131455
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.
Adachi M; Hoshino Y; Izumi Y; Sakai H; Takagi S
Can J Vet Res; 2016 Jul; 80(3):209-16. PubMed ID: 27408334
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.
Maxwell MJ; Goldie RG; Henry PJ
Br J Pharmacol; 1998 Dec; 125(8):1768-78. PubMed ID: 9886769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
